Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375102 · ClinicalTrials.gov registry record · Phase 2
Acupuncture and the Relaxation Response for Substance Abuse
A Phase 2 study, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- Phase 2
- Development phase
- 67
- Enrollment target
NCT00375102: Completed Phase 2 study, sponsored by VA Boston Healthcare System.
NCT00375102 is a Phase 2 study that has completed, run by VA Boston Healthcare System. The registered enrollment target is 67 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00375102, a Phase 2 study, has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 67 participants
- Enrollment target
Study Summary
This one-year pilot study has two specific aims: 1. to determine the feasibility of conducting a randomized controlled trial of acupuncture and the relaxation response for substance abuse among homeless veterans who are in a domiciliary care program, and 2. to collect and analyze pilot data to estimate the effect size for planning a future larger study to fully test the hypothesis of the effectiveness of acupuncture and the RR in reducing cravings for substances (alcohol and drugs), and the corollary effects on quality of life.
Interventions
- PROCEDURE Acupuncture
- BEHAVIORAL Relaxation Response
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
What the finished NCT00375102 record still lists
NCT00375102 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which Acupuncture is the first listed.
NCT00375102 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00375102 about?
NCT00375102 is a clinical study titled "Acupuncture and the Relaxation Response for Substance Abuse". This one-year pilot study has two specific aims: 1. to determine the feasibility of conducting a randomized controlled trial of acupuncture and the relaxation response for substance abuse among homeless veterans who are in a domiciliary care program, and 2. to collect and analyze pilot data to estim...
What is the current status of trial NCT00375102?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2006-11. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00375102?
The interventions under investigation include: Acupuncture (PROCEDURE), Relaxation Response (BEHAVIORAL).
Who is sponsoring clinical trial NCT00375102?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00375102's enrollment target sits among peer trials
67 974th of 2000 higher than 1,026 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia